Australia markets closed

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.01100.0000 (0.00%)
At close: 11:10AM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
618.568
618.568
99.73
-
2,615
Gross profit
618.568
618.568
99.73
-
2,615
Operating expenses
Research development
1,732
1,732
2,535
3,166
2,619
Selling general and administrative
6,500
6,500
9,679
8,230
4,792
Total operating expenses
10,210
10,210
14,212
12,667
8,005
Operating income or loss
-9,592
-9,592
-14,113
-12,667
-8,005
Interest expense
331.225
331.225
81.225
-
-
Total other income/expenses net
2,775
2,775
4,107
4,192
2,665
Income before tax
-7,130
-7,130
-10,084
-8,468
-5,279
Income tax expense
0
0
0
0
0
Income from continuing operations
-7,130
-7,130
-10,084
-8,468
-5,279
Net income
-7,130
-7,130
-10,084
-8,468
-5,279
Net income available to common shareholders
-7,130
-7,130
-10,084
-8,468
-5,279
Basic EPS
-0.04
-0.04
-0.06
-0.06
-0.05
Diluted EPS
-0.04
-0.04
-0.06
-0.06
-0.05
Basic average shares
177,717
196,894
177,696
147,634
106,267
Diluted average shares
177,717
196,894
177,696
147,634
106,267